Matthew R. Mcbrady Sells 2,000 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXONGet Free Report) Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now directly owns 4,892 shares in the company, valued at $1,783,916.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Axon Enterprise Trading Up 0.8 %

Shares of Axon Enterprise stock traded up $3.03 on Monday, reaching $368.03. The company had a trading volume of 545,387 shares, compared to its average volume of 527,190. The firm has a market cap of $27.77 billion, a price-to-earnings ratio of 106.73, a P/E/G ratio of 6.65 and a beta of 0.95. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55. The firm’s 50-day moving average price is $300.84 and its two-hundred day moving average price is $296.85. Axon Enterprise, Inc. has a 1 year low of $189.12 and a 1 year high of $375.95.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a return on equity of 9.73% and a net margin of 16.06%. The company’s quarterly revenue was up 34.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.80 EPS. As a group, research analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Axon Enterprise

Institutional investors and hedge funds have recently modified their holdings of the stock. Blue Trust Inc. boosted its holdings in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares during the period. ICA Group Wealth Management LLC purchased a new position in Axon Enterprise during the 4th quarter valued at $26,000. Trivant Custom Portfolio Group LLC purchased a new position in Axon Enterprise during the 1st quarter valued at $31,000. First PREMIER Bank purchased a new position in Axon Enterprise during the 1st quarter valued at $33,000. Finally, Blue Bell Private Wealth Management LLC purchased a new position in Axon Enterprise during the 1st quarter valued at $41,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several recent analyst reports. Needham & Company LLC reissued a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a research note on Wednesday, August 7th. Jefferies Financial Group initiated coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price on the stock. Barclays lifted their target price on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Craig Hallum lifted their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, Morgan Stanley lifted their target price on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $358.08.

Check Out Our Latest Report on AXON

Axon Enterprise Company Profile

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Insider Buying and Selling by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.